Arix Managing Director to Participate in Fireside Chat at the Jefferies Healthcare Conference (1246669)
November 08 2021 - 2:00AM
UK Regulatory
Arix Bioscience PLC (ARIX) Arix Managing Director to Participate
in Fireside Chat at the Jefferies Healthcare Conference 08-Nov-2021
/ 07:00 GMT/BST Dissemination of a Regulatory Announcement,
transmitted by EQS Group. The issuer is solely responsible for the
content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
Arix Managing Director to Participate in Fireside Chat at the
Jefferies Healthcare Conference
LONDON, 8 November 2021: Arix Bioscience plc ("Arix" or the
"Company") (LSE: ARIX), a global venture capital company focused on
investing in and building breakthrough biotech companies, today
announces that Mark Chin, Managing Director, is scheduled to
participate in a virtual analyst-led fireside chat with Matthew
Hose, Equity Research Analyst, at Jefferies London Healthcare
Conference taking place in person and virtually from 16-19 November
2021 in London.
A webcast of the fireside chat will be available on the
Jefferies conference portal and the replay will be available
afterwards on the Investor Relations section of Arix's website
here.
ENDS
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc +44 (0) 20 7290 1050
ir@arixbioscience.com
Optimum Strategic Communications
Mary Clark, Manel Mateus +44 (0)20 8078 4357
optimum.arix@optimumcomms.com
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused
on investing in and building breakthrough biotech companies around
cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the
capital, expertise and global networks to help accelerate their
ideas into important new treatments for patients. As a listed
company, we are able to bring this exciting growth phase of our
industry to a broader range of investors.
www.arixbioscience.com
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: MSCM
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 126161
EQS News ID: 1246669
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1246669&application_name=news
(END) Dow Jones Newswires
November 08, 2021 02:00 ET (07:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2024 to May 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From May 2023 to May 2024